Search company, investor...

Predict your next investment

Corporation

Investments

1

About LYC Medicare

LYC Medicare is a wholly-owned subsidiary of LYC Healthcare Bhd.

Headquarters Location

Malaysia

Want to inform investors similar to LYC Medicare about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest LYC Medicare News

LYC completes stake buy in S’pore clinics

Oct 12, 2022

PETALING JAYA: LYC Healthcare Bhd has completed its acquisition of the remaining 49% stake in Singapore specialist clinics, T&T Medical Group Pte Ltd and HC Orthopaedic Surgery Pte Ltd (HCOS) respectively. In a statement, LYC said the acquisitions were completed on Oct 10, 2022, via its wholly-owned subsidiary, LYC Medicare (Singapore) Pte Ltd (LYC Medicare SG). Managing director and group chief executive officer David Sui Diong Hoe said the acquisitions will allow LYC to attract more customers by leveraging T&T and HCOS’ expertise and experience in the medical field. T&T and HCOS provide general and specialised medical services, particularly in the treatment of chronic disease and osteoporosis. — Bernama Article type: free

LYC Medicare Investments

1 Investments

LYC Medicare has made 1 investments. Their latest investment was in HC Orthopaedic Surgery as part of their Secondary Market on May 5, 2020.

CBI Logo

LYC Medicare Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/28/2020

Secondary Market

HC Orthopaedic Surgery

$4.89M

Yes

1

Date

5/28/2020

Round

Secondary Market

Company

HC Orthopaedic Surgery

Amount

$4.89M

New?

Yes

Co-Investors

Sources

1

LYC Medicare Acquisitions

3 Acquisitions

LYC Medicare acquired 3 companies. Their latest acquisition was T&T Medical Group on March 16, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/16/2022

$99M

Acquired

3

3/16/2022

Subscribe to see more

$99M

Subscribe to see more

10

5/4/2020

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/16/2022

3/16/2022

5/4/2020

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

3

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.